Medical Technology Ireland

The Acrotec Group is consolidating the strengthening of its international MedTech division with the purchase, concluded on July 19, of Takumi, a company based in Limerick.

Founded in 1998, Takumi is recognized as a leading CNC precision engineering company. It currently employs 120 people at its Raheen Industrial Estate facility. It manufactures precision parts medical devices and other for highly regulated industries such as, aerospace, semiconductor and pharmaceutical. Takumi's products include orthopaedic implants and instruments, as well as a range of cardiovascular support systems and assembly aids.

"Culture is an essential cornerstone of any successful business. Acrotec's values, such as its entrepreneurial spirit, respect, integrity and independence, are a perfect fit for Takumi", said Donal Galligan, CEO of Takumi. "Our own values of expertise, competence, forward thinking, agility and focus will go a long way in supporting Acrotec's principles. This is an exciting new step in Takumi's history and so we look forward to joining the Acrotec family."

Ireland is home to more than 300 companies in the medical technology sector and many of Takumi's medical technology customers are U.S. multinationals with European headquarters near Takumi in the Limerick area.

"This geo-strategic positioning was a key factor in our decision, explains François Billig, CEO of the Acrotec Group. This Irish region plays the role of an industrial bridge between Europe and the United States in the MedTech field and Takumi has a solid reputation and industrial expertise that attracted us. This is great news for Acrotec and I would like to thank Takumi's management for their confidence and enthusiasm in joining us."

Gerry Reynolds, chairman and founder of Takumi, agrees: "I am very excited about this next step in the Takumi journey. I am confident that Takumi will thrive and grow as part of the Acrotec family of companies. Our culture will be maintained and we will continue to create value for our customers and shareholders while ensuring that Takumi remains a rewarding and fulfilling place to work."